Basic approaches to assessment of digital health products and services in the Russian Federation

Objective: To analyze the applicability of approaches conventionally used to assess the clinical and economic effectiveness of pharmaceuticals to that of digital health products and services (DHPS).

Material and methods. In this study, DHPS was considered to be an umbrella concept that encompasses various health technologies such as mobile health apps and services, including those based on artificial intelligence. Approaches to drug assessment were reviewed based on regulatory documents, methodological guidelines, and monographs on drugs assessment.

Results. The examined approaches to assessing the effectiveness and safety of pharmaceuticals can be applied to DHPS, having no fundamental limitations. Specific characteristics of DHPS that influence the choice of their assessment approaches were identified and described. A draft dossier for DHPS was proposed, with its composition aligned with the goals and objectives of the assessment task.

Conclusion. Future research should address the development of methodological guidelines for assessing DHPS based on the approaches used for drug assessment.

1. Omelyanovskiy V.V. (Ed.) Tracks of development and inclusion of medical technologies in clinical practice in the Russian Federation. Мoscow: Kachestvo zhizni; 2025: 54 pp. (in Russ.).

2. Rebrova O.Yu. Life cycle of decision support systems as medical technologies. Medical Doctor and IT. 2020; 1: 27–37 (in Russ.). https://doi.org/10.37690/1811-0193-2020-1-27-37.

3. Omelyanovskiy V.V., Avxentyeva M.V., Sura M.V., et al. Methodological recommendations for the evaluation of drug comparative clinical efficacy and safety. Мoscow: Center for Healthcare Quality Assessment and Control; 2016: 58 pp. (in Russ.).

4. Omelyanovskiy V.V., Avxentyeva M.V., Sura M.V., et al. Methodological recommendations for conducting a comparative clinical and economic evaluation of a medicinal product. Мoscow: Center for Healthcare Quality Assessment and Control; 2019: 44 pp. (in Russ.).

5. Omelyanovskiy V.V., Avxentyeva M.V. (Eds) Health technology assessment. Мoscow: Nauka; 2025: 389 pp. (in Russ.).

6. Vorobyev P.A. (Ed.) Clinical and economic analysis. 3rd ed. Мoscow: Nyudiamed; 2008: 778 pp. (in Russ.).

7. Rebrova O.Yu., Gusev A.V. Sample size calculation for clinical trials of medical decision support systems with binary outcome. Modern Technologies in Medicine. 2022; 14 (3): 6–14 (in Russ.). https://doi.org/10.17691/stm2022.14.3.01.

8. Ar’kova E.S., Luchinin E.A., Kornilova E.B., et al. Key recommendations for assessing medical devices: new in HTA. In: Proceedings of the Research Institute of Healthcare Organization and Medical Management: a collection of scientific papers. Мoscow: Research Institute of Healthcare Organization and Medical Management; 2021: 85–90 (in Russ.).

9. Fletcher R.H., Fletcher S.W., Wagner E.H. Clinical epidemiology: the essentials. Williams & Wilkins; 1996: 276 pp.

10. Guyatt G., Rennie D. Users' guides to the medical literature: a manual for evidence-based clinical practice. Amer Medical Assn; 2002: 672 pp.

11. Rebrova O.Yu. Statistical analysis of medical data. Using the Statistica software package. Мoscow: Media Sfera; 2006: 305 pp. (in Russ.).